


Healthcare Industry News: S.A.
News Release - November 11, 2020
Pablo Alvarez appointed to President and GM of Almirall US
Pablo will report directly to the CEO and serve on the Management Board effective immediatelyHe brings to this important role broad international pharmaceutical industry experience, including nearly 10 years in the US
Almirall US is poised for growth under strengthened leadership
BARCELONA, S.A.n, Nov. 11, 2020 -- (Healthcare Sales & Marketing Network) -- Almirall, S.A. (ALM) the global biopharmaceutical company based in Barcelona, haS.A.nounced that Pablo Alvarez has been promoted and will become the new President & GM of Almirall US, reporting directly to the CEO and serving on the Management Board effective immediately.
Pablo has previously served as Commercial Operations Director, overseeing several market companies such as the UK, Netherlands, Nordics, Belgium and France, as well as heading a number of global functions during which he gained extensive experience in medical dermatology.
Before joining Almirall, Pablo worked for McKinsey, GSK, BMS.A.d AstraZeneca including key positions in Europe, LatAm and China and, importantly, nine years in the US. He has deep experience in launching products, implementing new business models, expanding to new geographieS.A.d strategy development. Pablo haS.A.PhD in Pharmacy, with a focus on Microbiology from the Complutense University (Madrid, S.A.n), carried out a postdoctoral reS.A.ch at MIT (Boston, United S.A.es) and studied businesS.A.d management at IESE Business School (Barcelona, S.A.n).
According to Peter Guenter, CEO of Almirall, "Pablo will immediately add value with his extensive international commercial experience. HiS.A.pointment iS.A.clear opportunity to further strengthen Almirall's presence in the US market, drive the uptake of Seysara® (sarecycline) and ensure a successful launch of tirbanibulin, an innovative therapy for the management of Actinic Keratosis. Always with a clear focus on what is important for the business, he S.A.ds out for his great leadership, strategic thinking, analytical skillS.A.d ability to drive and manage change. We are proud of this internal promotion as it iS.A. example of our commitment at Almirall towards our internal talent and the success of our talent review and succession planning process."
Pablo S.A.ed, "I am delighted to be leading a strong and experienced team, and to continue to build Almirall's presence and medical dermatology portfolio in the US. I am proud of the commitment to innovation and the patient centric approach that guides everything we do at Almirall, and I look forward to working with the team and the dermatology community in the US to bring further treatments that benefit those patients."
We would like to thank Ron Menezes for his work and dedication to the company during the last 3 years. We wish him all the best in his future projects in his home S.A.e of California.
Source: Almirall
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
